Deciphera Pharmaceuticals Inc (DCPH)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

200 SMITH STREET WALTHAM, MA 02451

Deciphera Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops kinase inhibitor treatments for various type of cancer diseases including gastrointestinal, stromal tumors, advance systemic mastocytosis, gliomas, and other solid tumors. Deciphera Pharmaceuticals serves patients globally.

Data as of 2020-07-04
Market Cap3.168 Billion Shares Outstanding55.859 Million Avg 30-day Volume545.431 Thousand
P/E Ratio Dividend Yield EPS-4.56
Price/Sales51093.2 Price cash flow ratio Price free cash flow ratio-19.2
Book Value12.03 Price to Tangible Book4.71 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low71.11 / 19.88 Stddev
View SEC Filings from DCPH instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 5 4 (0.26%)
13F Filers holding this stock: 146 51 (3.34%)
Aggregate 13F shares on 03/31/2020: 40.187 Million 25.431 Million
Aggregate 13F shares on 12/31/2019: 35.588 Million 21.576 Million
Percent change: 12.92% 17.87%
Funds creating new positions: 30 11
Funds Adding to an existing position: 58 26
Funds closing out their position: 36 18
Funds reducing their position: 41 10
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding DCPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DCPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

24 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

24.4 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KELLEY SUSAN L.

  • Director
0 2020-06-25 3

SHERMAN MATTHEW L

0 2020-06-23 3

HOERTER STEVEN L. PRESIDENT AND CEO

  • Officer
  • Director
42,392 2020-06-18 5

ALLEN PATRICIA L

  • Director
0 2020-06-10 3

TAYLOR MICHAEL DOUGLAS

  • Director
0 2020-06-10 10

WALSH DENNIS LEO

  • Director
0 2020-06-10 1

BENZ EDWARD J. JR

  • Director
0 2020-06-10 1

MARTIN JOHN RICHARD

  • Director
0 2020-06-10 1

BRISTOL JAMES ARTHUR

  • Director
0 2020-06-10 5

FRIEDMAN FRANKLIN STUART

  • Director
0 2020-06-10 4

SQUARER RON

  • Director
0 2020-06-10 4

RATCLIFFE LIAM

  • Director
0 2020-06-03 0

KELLY THOMAS PATRICK CHIEF FINANCIAL OFFICER

  • Officer
7,040 2020-05-11 7

FLYNN DANIEL LEE CHIEF SCIENTIFIC OFFICER

  • Officer
189,466 2020-02-18 8

MARTIN DANIEL C. CHIEF COMMERCIAL OFFICER

  • Officer
17,000 2020-01-22 2

MORL CHRISTOPHER JOHN CHIEF BUSINESS OFFICER

  • Officer
0 2020-01-15 6

NEW LEAF VENTURE MANAGEMENT III, L.L.C.

NEW LEAF VENTURES III, L.P.

NEW LEAF BIOPHARMA OPPORTUNITIES I, L.P.

NEW LEAF VENTURE ASSOCIATES III, L.P.

NEW LEAF BPO ASSOCIATES I, L.P.

  • 10% Owner
7,708,280 2019-08-15 1

ROSS MICHAEL JAY

  • Director
0 2019-06-11 0

RUDDY STEPHEN B. CHIEF TECHNICAL OFFICER

  • Officer
0 2019-01-30 0

BRIGHTSTAR ASSOCIATES LLC

  • 10% Owner
16,572,370 2017-10-02 0

ROSEN OLIVER CHIEF MEDICAL OFFICER

  • Officer
0 2017-10-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2020-06-18 A 187 d 397,188 42,392.00 direct

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2020-06-18 M 187 $25.40 a 42,392 42,392.00 direct

FRIEDMAN FRANKLIN STUART - Director

2020-06-10 A 12,000 a 12,000 0.00 direct

TAYLOR MICHAEL DOUGLAS - Director

2020-06-10 A 12,000 a 12,000 0.00 direct

MARTIN JOHN RICHARD - Director

2020-06-10 A 12,000 a 12,000 0.00 direct

BENZ EDWARD J. JR - Director

2020-06-10 A 12,000 a 12,000 0.00 direct

ALLEN PATRICIA L - Director

2020-06-10 A 12,000 a 12,000 0.00 direct

WALSH DENNIS LEO - Director

2020-06-10 A 12,000 a 12,000 0.00 direct

KELLEY SUSAN L. - Director

2020-06-10 A 12,000 a 12,000 0.00 direct

SQUARER RON - Director

2020-06-10 A 12,000 a 12,000 0.00 direct

BRISTOL JAMES ARTHUR - Director

2020-06-10 A 12,000 a 12,000 0.00 direct

ALLEN PATRICIA L - Director

2020-06-05 M 5,635 d 0 0.00 direct

ALLEN PATRICIA L - Director

2020-06-05 M 5,635 $25.73 a 5,635 0.00 direct

ALLEN PATRICIA L - Director

2020-06-05 S 5,635 $55.90 d 0 0.00 direct

ALLEN PATRICIA L - Director

2020-06-03 M 6,365 d 5,635 0.00 direct

ALLEN PATRICIA L - Director

2020-06-03 S 6,365 $59.14 d 0 0.00 direct

ALLEN PATRICIA L - Director

2020-06-03 M 6,365 $25.73 a 6,365 0.00 direct

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2020-05-28 A 188 d 397,375 42,205.00 direct

HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO

2020-05-28 M 188 $25.40 a 42,205 42,205.00 direct

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2020-05-11 M 12,000 $1.89 a 19,040 7,040.00 direct

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2020-05-11 S 2,605 $55.56 d 7,040 7,040.00 direct yes

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2020-05-11 S 9,395 $55.08 d 9,645 7,040.00 direct yes

KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER

2020-05-11 M 12,000 d 59,008 7,040.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments